Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CT Colonography Screening Shows Promise If Cost Lowered, MedCAC Says

This article was originally published in The Gray Sheet

Executive Summary

Computed tomography colonography shows promise as a colorectal cancer screening tool comparable to optical colonoscopy, and could be covered under Medicare, but the price per procedure would have to be lowered, members of a CMS advisory panel agreed Nov. 19

You may also be interested in...



Blues TEC Joins Chorus: CT Colonography Works, But Costs Too Much

The BlueCross BlueShield Technology Evaluation Center is adding its voice to a growing consensus around CT colonography, saying the procedure is effective in screening for colon cancer but is not cost-effective compared to colonoscopy

Blues TEC Joins Chorus: CT Colonography Works, But Costs Too Much

The BlueCross BlueShield Technology Evaluation Center is adding its voice to a growing consensus around CT colonography, saying the procedure is effective in screening for colon cancer but is not cost-effective compared to colonoscopy

Protests Mount Over CMS Proposal To Deny Virtual Colonoscopy Coverage

Lawmakers, medical societies and patient advocacy groups joined the medtech industry last week in urging CMS to reverse its plan to deny coverage for computed tomography colonography to screen for colorectal cancer

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026814

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel